Home › Research › Inflammation and the immune system
The association of Alzheimer's disease and related dementias blood‐based biomarkers with depressive symptoms
Julia R. Bacci, Joanne L. Ryan, Anne M. Murray, Zimu Wu, Robyn L. Woods, Michael Berk, Michelle M. Mielke. Alzheimer s & Dementia, 2025-12-31
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Higher glial fibrillary acidic protein (GFAP) was associated with higher depressive symptoms. We did not observe an association between amyloid beta 42/40 ratio, phosphorylated tau181, or neurofilament light chain with depressive symptoms; interactions between sex or APOE ε4 with depressive symptoms were not significant. In this large, community-based cohort of older adults, plasma GFAP was associated with greater depressive symptoms. HIGHLIGHTS: Plasma glial fibrillary acidic protein was associated with depressive symptoms. Neuroinflammation may underlie depressive symptoms in this group. Future research is needed to examine sex differences in this association.
What this study adds
Evidence grade: Moderate
This is a cross-sectional study. In a large community cohort, higher plasma GFAP was associated with more depressive symptoms, while amyloid beta 42/40 ratio, phosphorylated tau181 and neurofilament light chain were not. This cross-sectional finding links a marker to symptoms but does not show any treatment or prevention effect.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Bacci, J. R., Ryan, J. L., Murray, A. M., Wu, Z., Woods, R. L., Berk, M., et al. (2025). The association of Alzheimer's disease and related dementias blood‐based biomarkers with depressive symptoms. Alzheimer s & Dementia. https://doi.org/10.1002/alz.71007
Vancouver
Bacci JR, Ryan JL, Murray AM, Wu Z, Woods RL, Berk M, et al. The association of Alzheimer's disease and related dementias blood‐based biomarkers with depressive symptoms. Alzheimer s & Dementia. 2025. doi:10.1002/alz.71007. PMID: 41476029.
BibTeX
@article{bacci2025-41476029,
author = {Bacci, Julia R. and Ryan, Joanne L. and Murray, Anne M. and Wu, Zimu and Woods, Robyn L. and Berk, Michael and Mielke, Michelle M.},
title = {{The association of Alzheimer's disease and related dementias blood‐based biomarkers with depressive symptoms}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz.71007},
pmid = {41476029},
url = {https://doi.org/10.1002/alz.71007}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Higher glial fibrillary acidic protein (GFAP) was associated with higher depressive symptoms.
- We did not observe an association between amyloid beta 42/40 ratio, phosphorylated tau181, or neurofilament light chain with depressive symptoms; interactions between sex or APOE ε4 with depressive symptoms were not significant.
- In this large, community-based cohort of older adults, plasma GFAP was associated with greater depressive symptoms.
- HIGHLIGHTS: Plasma glial fibrillary acidic protein was associated with depressive symptoms.
- Neuroinflammation may underlie depressive symptoms in this group.
Why it matters
In a large community cohort, higher plasma GFAP was associated with more depressive symptoms, while amyloid beta 42/40 ratio, phosphorylated tau181 and neurofilament light chain were not. This cross-sectional finding links a marker to symptoms but does not show any treatment or prevention effect.
Study details
- Study designcross-sectional
- Evidence strengthModerate
How this study scored 46/100
Published in a peer-reviewed journal, and it is a snapshot of people at one point in time. Scored zero for sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 4 / 12 | A snapshot of people at one point in time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 4 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 2.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Michelle M. Mielke: h-index 112 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Monash University: institution h-index 1,146 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 6 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41476029) |
| Free to read | 2 / 2 | Free to read |
| Total | 46 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Inflammation and the immune system from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.